| 1 | serve | 2,973 |
| 2 | serves | 732 |
| 3 | qualifies | 16 |
| 4 | self-identify | 16 |
| 5 | masquerade | 8 |
| 6 | scrunch | 4 |
| 7 | self-identifying | 4 |
| 8 | carbonate-apatite | 3 |
| 9 | multivessels | 3 |
| 10 | outcross | 3 |
| 11 | 1-ethylpyrazole-3-carboxamide | 2 |
| 12 | 2001/83/ec | 2 |
| 13 | 3-hydroxycyclobutane-1,1-dicarboxylate | 2 |
| 14 | 3-methyl-2-vinylindoles | 2 |
| 15 | amine-3-quinolinecarbonitriles | 2 |
| 16 | cbinsl3 | 2 |
| 17 | decompensate | 2 |
| 18 | ewe-lamb | 2 |
| 19 | medicalise | 2 |
| 20 | neglectus | 2 |
| 21 | one-of-a-kind | 2 |
| 22 | re-transfuse | 2 |
| 23 | self-injure | 2 |
| 24 | ''ultrasound | 1 |
| 25 | 'grandparent | 1 |
| 26 | -1065 | 1 |
| 27 | -ii-studies | 1 |
| 28 | /ga/ | 1 |
| 29 | 0.079μm | 1 |
| 30 | 0.2…0.3 | 1 |
| 31 | 02-5b-318r | 1 |
| 32 | 1,2,4-trichlorodibenzo-p-dioxin | 1 |
| 33 | 1,2-ethylenediamine | 1 |
| 34 | 1,2-gdn | 1 |
| 35 | 1,3-di-amino-propane | 1 |
| 36 | 1-trimethylsilylbicyclobutane | 1 |
| 37 | 1022.2 | 1 |
| 38 | 1122-1135 | 1 |
| 39 | 14.5-12.0 | 1 |
| 40 | 1598- | 1 |
| 41 | 2,3-butadienoates | 1 |
| 42 | 2,3-diols | 1 |
| 43 | 2-ketoglutaraldehyde | 1 |
| 44 | 2-thioxo-1,3-oxazines | 1 |
| 45 | 2004.grey | 1 |
| 46 | 24-methylcholest-5-en-3β-ol | 1 |
| 47 | 3-4-5-0 | 1 |
| 48 | 3-azaxanthenes | 1 |
| 49 | 3-bromo-4-hexylthiophene | 1 |
| 50 | 30-300mg/g | 1 |
| 51 | 4-hydroxyprolines | 1 |
| 52 | 4s,5s-configuration | 1 |
| 53 | 5-fluorouracil-either | 1 |
| 54 | 51crcl3 | 1 |
| 55 | 5α-h-3-one | 1 |
| 56 | 7-o-rhamnosides | 1 |
| 57 | 8,315 | 1 |
| 58 | 97de | 1 |
| 59 | =0.423 | 1 |
| 60 | =1992 | 1 |
| 61 | a-308a | 1 |
| 62 | ach-iontophoresis | 1 |
| 63 | acrgis | 1 |
| 64 | age-ldls | 1 |
| 65 | amylogum | 1 |
| 66 | analysis-such | 1 |
| 67 | asp35 | 1 |
| 68 | at17.6b | 1 |
| 69 | at2-blockers | 1 |
| 70 | beadjusted | 1 |
| 71 | bordas | 1 |
| 72 | borealis | 1 |
| 73 | c66 | 1 |
| 74 | catagorized | 1 |
| 75 | chlorobutane | 1 |
| 76 | chloroperoxidase | 1 |
| 77 | cis-adhesion | 1 |
| 78 | city/town | 1 |
| 79 | clenbuterol-d9 | 1 |
| 80 | coeducation | 1 |
| 81 | coronene-like | 1 |
| 82 | cost-pressures | 1 |
| 83 | csf/cubr | 1 |
| 84 | cv12472 | 1 |
| 85 | cyanogels | 1 |
| 86 | cys432 | 1 |
| 87 | daunorubicin/cytarabine/etoposide | 1 |
| 88 | decylamine | 1 |
| 89 | dentin-restricted | 1 |
| 90 | diet-therapy | 1 |
| 91 | donezepil | 1 |
| 92 | dose*month | 1 |
| 93 | dtpa-solution | 1 |
| 94 | dys1 | 1 |
| 95 | e.agglomerans | 1 |
| 96 | education-act | 1 |
| 97 | emea/cpmp | 1 |
| 98 | epi-marker | 1 |
| 99 | exhausters | 1 |
| 100 | ficantly | 1 |
| 101 | fine-grinding | 1 |
| 102 | forward-biased | 1 |
| 103 | germline-mutations | 1 |
| 104 | gerontologists | 1 |
| 105 | gln817 | 1 |
| 106 | glucose-elevations | 1 |
| 107 | gly-x-gly | 1 |
| 108 | glymes | 1 |
| 109 | gmmyb62 | 1 |
| 110 | good-working | 1 |
| 111 | gray-weale | 1 |
| 112 | groove/strands | 1 |
| 113 | hd-group | 1 |
| 114 | hemotoxins | 1 |
| 115 | hio3 | 1 |
| 116 | hydrochlorothyazide | 1 |
| 117 | hydroxyethyl-beta-cd | 1 |
| 118 | il-8/il-10 | 1 |
| 119 | ilha | 1 |
| 120 | immunoregulator | 1 |
| 121 | incongruities | 1 |
| 122 | intraprosthetic | 1 |
| 123 | iodophors | 1 |
| 124 | ir-quartz | 1 |
| 125 | isooctane | 1 |
| 126 | koac | 1 |
| 127 | krk-0104-trial | 1 |
| 128 | l-cystathionine | 1 |
| 129 | lanthana | 1 |
| 130 | legacy-building | 1 |
| 131 | levoamphetamine | 1 |
| 132 | ligament-tears | 1 |
| 133 | lys-123 | 1 |
| 134 | m27-a3 | 1 |
| 135 | mc-cfdps | 1 |
| 136 | metronidazole-neomycin | 1 |
| 137 | miscarriage.selenomethionine | 1 |
| 138 | mm-pyruvate | 1 |
| 139 | mmu-mir-574-5p | 1 |
| 140 | molecular-chemotherapy | 1 |
| 141 | multinodularity | 1 |
| 142 | n-acetylgycosamine | 1 |
| 143 | nano-wells | 1 |
| 144 | neo-ι-carratetraose | 1 |
| 145 | neoagarohexaose | 1 |
| 146 | neurotransmitters-possibly | 1 |
| 147 | nn2211 | 1 |
| 148 | non-anthracyclines | 1 |
| 149 | nondiuretics | 1 |
| 150 | nonpregnancies | 1 |
| 151 | nonrapists | 1 |
| 152 | p.gly264ser | 1 |
| 153 | pasture-management | 1 |
| 154 | pbtz-169 | 1 |
| 155 | pejoratively | 1 |
| 156 | pentachlorocyclohexenes | 1 |
| 157 | perturbate | 1 |
| 158 | phospho-p70s6k | 1 |
| 159 | phosphohydroxypyruvate | 1 |
| 160 | pkczeta | 1 |
| 161 | project-known | 1 |
| 162 | propofal | 1 |
| 163 | psba3r | 1 |
| 164 | p≤0·01 | 1 |
| 165 | re-packaging | 1 |
| 166 | regranulation | 1 |
| 167 | remyelinate | 1 |
| 168 | rihua | 1 |
| 169 | robinetin | 1 |
| 170 | rpe-1 | 1 |
| 171 | rps15a | 1 |
| 172 | rs1520177 | 1 |
| 173 | sba-15/ab₂ | 1 |
| 174 | sc7 | 1 |
| 175 | scratch/patch | 1 |
| 176 | sigmah | 1 |
| 177 | stanniocalcin-1 | 1 |
| 178 | t-511t | 1 |
| 179 | tae/angiography | 1 |
| 180 | time-after-second-dose | 1 |
| 181 | time-efficacy | 1 |
| 182 | time-to-dropout | 1 |
| 183 | tout | 1 |
| 184 | trans-3-bromoacrylate | 1 |
| 185 | transcriptional-levels | 1 |
| 186 | triclosan/copolymer/naf | 1 |
| 187 | typaldos | 1 |
| 188 | udp-rhamnose | 1 |
| 189 | vas-totpar | 1 |
| 190 | vector-designated | 1 |
| 191 | vitagram | 1 |
| 192 | westerns | 1 |
| 193 | whib4 | 1 |
| 194 | world-knowledge | 1 |
| 195 | β-1,3-xylotriose | 1 |
| 196 | δ-isomers | 1 |
| 197 | σcc | 1 |
| 1 | ''ultrasound | 1 |
| 2 | 'grandparent | 1 |
| 3 | -1065 | 1 |
| 4 | -ii-studies | 1 |
| 5 | /ga/ | 1 |
| 6 | 0.079μm | 1 |
| 7 | 0.2…0.3 | 1 |
| 8 | 02-5b-318r | 1 |
| 9 | 1,2,4-trichlorodibenzo-p-dioxin | 1 |
| 10 | 1,2-ethylenediamine | 1 |
| 11 | 1,2-gdn | 1 |
| 12 | 1,3-di-amino-propane | 1 |
| 13 | 1-ethylpyrazole-3-carboxamide | 2 |
| 14 | 1-trimethylsilylbicyclobutane | 1 |
| 15 | 1022.2 | 1 |
| 16 | 1122-1135 | 1 |
| 17 | 14.5-12.0 | 1 |
| 18 | 1598- | 1 |
| 19 | 2,3-butadienoates | 1 |
| 20 | 2,3-diols | 1 |
| 21 | 2-ketoglutaraldehyde | 1 |
| 22 | 2-thioxo-1,3-oxazines | 1 |
| 23 | 2001/83/ec | 2 |
| 24 | 2004.grey | 1 |
| 25 | 24-methylcholest-5-en-3β-ol | 1 |
| 26 | 3-4-5-0 | 1 |
| 27 | 3-azaxanthenes | 1 |
| 28 | 3-bromo-4-hexylthiophene | 1 |
| 29 | 3-hydroxycyclobutane-1,1-dicarboxylate | 2 |
| 30 | 3-methyl-2-vinylindoles | 2 |
| 31 | 30-300mg/g | 1 |
| 32 | 4-hydroxyprolines | 1 |
| 33 | 4s,5s-configuration | 1 |
| 34 | 5-fluorouracil-either | 1 |
| 35 | 51crcl3 | 1 |
| 36 | 5α-h-3-one | 1 |
| 37 | 7-o-rhamnosides | 1 |
| 38 | 8,315 | 1 |
| 39 | 97de | 1 |
| 40 | =0.423 | 1 |
| 41 | =1992 | 1 |
| 42 | a-308a | 1 |
| 43 | ach-iontophoresis | 1 |
| 44 | acrgis | 1 |
| 45 | age-ldls | 1 |
| 46 | amine-3-quinolinecarbonitriles | 2 |
| 47 | amylogum | 1 |
| 48 | analysis-such | 1 |
| 49 | asp35 | 1 |
| 50 | at17.6b | 1 |
| 51 | at2-blockers | 1 |
| 52 | beadjusted | 1 |
| 53 | bordas | 1 |
| 54 | borealis | 1 |
| 55 | c66 | 1 |
| 56 | carbonate-apatite | 3 |
| 57 | catagorized | 1 |
| 58 | cbinsl3 | 2 |
| 59 | chlorobutane | 1 |
| 60 | chloroperoxidase | 1 |
| 61 | cis-adhesion | 1 |
| 62 | city/town | 1 |
| 63 | clenbuterol-d9 | 1 |
| 64 | coeducation | 1 |
| 65 | coronene-like | 1 |
| 66 | cost-pressures | 1 |
| 67 | csf/cubr | 1 |
| 68 | cv12472 | 1 |
| 69 | cyanogels | 1 |
| 70 | cys432 | 1 |
| 71 | daunorubicin/cytarabine/etoposide | 1 |
| 72 | decompensate | 2 |
| 73 | decylamine | 1 |
| 74 | dentin-restricted | 1 |
| 75 | diet-therapy | 1 |
| 76 | donezepil | 1 |
| 77 | dose*month | 1 |
| 78 | dtpa-solution | 1 |
| 79 | dys1 | 1 |
| 80 | e.agglomerans | 1 |
| 81 | education-act | 1 |
| 82 | emea/cpmp | 1 |
| 83 | epi-marker | 1 |
| 84 | ewe-lamb | 2 |
| 85 | exhausters | 1 |
| 86 | ficantly | 1 |
| 87 | fine-grinding | 1 |
| 88 | forward-biased | 1 |
| 89 | germline-mutations | 1 |
| 90 | gerontologists | 1 |
| 91 | gln817 | 1 |
| 92 | glucose-elevations | 1 |
| 93 | gly-x-gly | 1 |
| 94 | glymes | 1 |
| 95 | gmmyb62 | 1 |
| 96 | good-working | 1 |
| 97 | gray-weale | 1 |
| 98 | groove/strands | 1 |
| 99 | hd-group | 1 |
| 100 | hemotoxins | 1 |
| 101 | hio3 | 1 |
| 102 | hydrochlorothyazide | 1 |
| 103 | hydroxyethyl-beta-cd | 1 |
| 104 | il-8/il-10 | 1 |
| 105 | ilha | 1 |
| 106 | immunoregulator | 1 |
| 107 | incongruities | 1 |
| 108 | intraprosthetic | 1 |
| 109 | iodophors | 1 |
| 110 | ir-quartz | 1 |
| 111 | isooctane | 1 |
| 112 | koac | 1 |
| 113 | krk-0104-trial | 1 |
| 114 | l-cystathionine | 1 |
| 115 | lanthana | 1 |
| 116 | legacy-building | 1 |
| 117 | levoamphetamine | 1 |
| 118 | ligament-tears | 1 |
| 119 | lys-123 | 1 |
| 120 | m27-a3 | 1 |
| 121 | masquerade | 8 |
| 122 | mc-cfdps | 1 |
| 123 | medicalise | 2 |
| 124 | metronidazole-neomycin | 1 |
| 125 | miscarriage.selenomethionine | 1 |
| 126 | mm-pyruvate | 1 |
| 127 | mmu-mir-574-5p | 1 |
| 128 | molecular-chemotherapy | 1 |
| 129 | multinodularity | 1 |
| 130 | multivessels | 3 |
| 131 | n-acetylgycosamine | 1 |
| 132 | nano-wells | 1 |
| 133 | neglectus | 2 |
| 134 | neo-ι-carratetraose | 1 |
| 135 | neoagarohexaose | 1 |
| 136 | neurotransmitters-possibly | 1 |
| 137 | nn2211 | 1 |
| 138 | non-anthracyclines | 1 |
| 139 | nondiuretics | 1 |
| 140 | nonpregnancies | 1 |
| 141 | nonrapists | 1 |
| 142 | one-of-a-kind | 2 |
| 143 | outcross | 3 |
| 144 | p.gly264ser | 1 |
| 145 | pasture-management | 1 |
| 146 | pbtz-169 | 1 |
| 147 | pejoratively | 1 |
| 148 | pentachlorocyclohexenes | 1 |
| 149 | perturbate | 1 |
| 150 | phospho-p70s6k | 1 |
| 151 | phosphohydroxypyruvate | 1 |
| 152 | pkczeta | 1 |
| 153 | project-known | 1 |
| 154 | propofal | 1 |
| 155 | psba3r | 1 |
| 156 | p≤0·01 | 1 |
| 157 | qualifies | 16 |
| 158 | re-packaging | 1 |
| 159 | re-transfuse | 2 |
| 160 | regranulation | 1 |
| 161 | remyelinate | 1 |
| 162 | rihua | 1 |
| 163 | robinetin | 1 |
| 164 | rpe-1 | 1 |
| 165 | rps15a | 1 |
| 166 | rs1520177 | 1 |
| 167 | sba-15/ab₂ | 1 |
| 168 | sc7 | 1 |
| 169 | scratch/patch | 1 |
| 170 | scrunch | 4 |
| 171 | self-identify | 16 |
| 172 | self-identifying | 4 |
| 173 | self-injure | 2 |
| 174 | serve | 2,973 |
| 175 | serves | 732 |
| 176 | sigmah | 1 |
| 177 | stanniocalcin-1 | 1 |
| 178 | t-511t | 1 |
| 179 | tae/angiography | 1 |
| 180 | time-after-second-dose | 1 |
| 181 | time-efficacy | 1 |
| 182 | time-to-dropout | 1 |
| 183 | tout | 1 |
| 184 | trans-3-bromoacrylate | 1 |
| 185 | transcriptional-levels | 1 |
| 186 | triclosan/copolymer/naf | 1 |
| 187 | typaldos | 1 |
| 188 | udp-rhamnose | 1 |
| 189 | vas-totpar | 1 |
| 190 | vector-designated | 1 |
| 191 | vitagram | 1 |
| 192 | westerns | 1 |
| 193 | whib4 | 1 |
| 194 | world-knowledge | 1 |
| 195 | β-1,3-xylotriose | 1 |
| 196 | δ-isomers | 1 |
| 197 | σcc | 1 |
| 1 | 1598- | 1 |
| 2 | /ga/ | 1 |
| 3 | 3-4-5-0 | 1 |
| 4 | 14.5-12.0 | 1 |
| 5 | il-8/il-10 | 1 |
| 6 | rpe-1 | 1 |
| 7 | stanniocalcin-1 | 1 |
| 8 | p≤0·01 | 1 |
| 9 | nn2211 | 1 |
| 10 | dys1 | 1 |
| 11 | 1022.2 | 1 |
| 12 | cys432 | 1 |
| 13 | gmmyb62 | 1 |
| 14 | cv12472 | 1 |
| 15 | =1992 | 1 |
| 16 | 0.2…0.3 | 1 |
| 17 | lys-123 | 1 |
| 18 | =0.423 | 1 |
| 19 | m27-a3 | 1 |
| 20 | 51crcl3 | 1 |
| 21 | cbinsl3 | 2 |
| 22 | hio3 | 1 |
| 23 | whib4 | 1 |
| 24 | 8,315 | 1 |
| 25 | 1122-1135 | 1 |
| 26 | asp35 | 1 |
| 27 | -1065 | 1 |
| 28 | c66 | 1 |
| 29 | gln817 | 1 |
| 30 | rs1520177 | 1 |
| 31 | sc7 | 1 |
| 32 | pbtz-169 | 1 |
| 33 | clenbuterol-d9 | 1 |
| 34 | rps15a | 1 |
| 35 | a-308a | 1 |
| 36 | ilha | 1 |
| 37 | lanthana | 1 |
| 38 | pkczeta | 1 |
| 39 | rihua | 1 |
| 40 | at17.6b | 1 |
| 41 | ewe-lamb | 2 |
| 42 | koac | 1 |
| 43 | σcc | 1 |
| 44 | 2001/83/ec | 2 |
| 45 | intraprosthetic | 1 |
| 46 | hydroxyethyl-beta-cd | 1 |
| 47 | forward-biased | 1 |
| 48 | vector-designated | 1 |
| 49 | dentin-restricted | 1 |
| 50 | beadjusted | 1 |
| 51 | catagorized | 1 |
| 52 | one-of-a-kind | 2 |
| 53 | ''ultrasound | 1 |
| 54 | 97de | 1 |
| 55 | masquerade | 8 |
| 56 | 1-ethylpyrazole-3-carboxamide | 2 |
| 57 | daunorubicin/cytarabine/etoposide | 1 |
| 58 | hydrochlorothyazide | 1 |
| 59 | 2-ketoglutaraldehyde | 1 |
| 60 | world-knowledge | 1 |
| 61 | coronene-like | 1 |
| 62 | gray-weale | 1 |
| 63 | 1,3-di-amino-propane | 1 |
| 64 | isooctane | 1 |
| 65 | 1-trimethylsilylbicyclobutane | 1 |
| 66 | chlorobutane | 1 |
| 67 | 3-bromo-4-hexylthiophene | 1 |
| 68 | 1,2-ethylenediamine | 1 |
| 69 | decylamine | 1 |
| 70 | n-acetylgycosamine | 1 |
| 71 | levoamphetamine | 1 |
| 72 | l-cystathionine | 1 |
| 73 | miscarriage.selenomethionine | 1 |
| 74 | 5α-h-3-one | 1 |
| 75 | self-injure | 2 |
| 76 | chloroperoxidase | 1 |
| 77 | medicalise | 2 |
| 78 | neo-ι-carratetraose | 1 |
| 79 | neoagarohexaose | 1 |
| 80 | time-after-second-dose | 1 |
| 81 | β-1,3-xylotriose | 1 |
| 82 | udp-rhamnose | 1 |
| 83 | re-transfuse | 2 |
| 84 | perturbate | 1 |
| 85 | trans-3-bromoacrylate | 1 |
| 86 | 3-hydroxycyclobutane-1,1-dicarboxylate | 2 |
| 87 | remyelinate | 1 |
| 88 | decompensate | 2 |
| 89 | mm-pyruvate | 1 |
| 90 | phosphohydroxypyruvate | 1 |
| 91 | carbonate-apatite | 3 |
| 92 | serve | 2,973 |
| 93 | triclosan/copolymer/naf | 1 |
| 94 | 30-300mg/g | 1 |
| 95 | legacy-building | 1 |
| 96 | fine-grinding | 1 |
| 97 | re-packaging | 1 |
| 98 | good-working | 1 |
| 99 | self-identifying | 4 |
| 100 | sigmah | 1 |
| 101 | scrunch | 4 |
| 102 | scratch/patch | 1 |
| 103 | analysis-such | 1 |
| 104 | dose*month | 1 |
| 105 | phospho-p70s6k | 1 |
| 106 | propofal | 1 |
| 107 | krk-0104-trial | 1 |
| 108 | donezepil | 1 |
| 109 | 24-methylcholest-5-en-3β-ol | 1 |
| 110 | vitagram | 1 |
| 111 | amylogum | 1 |
| 112 | 0.079μm | 1 |
| 113 | 1,2-gdn | 1 |
| 114 | metronidazole-neomycin | 1 |
| 115 | robinetin | 1 |
| 116 | 1,2,4-trichlorodibenzo-p-dioxin | 1 |
| 117 | cis-adhesion | 1 |
| 118 | coeducation | 1 |
| 119 | regranulation | 1 |
| 120 | 4s,5s-configuration | 1 |
| 121 | dtpa-solution | 1 |
| 122 | project-known | 1 |
| 123 | city/town | 1 |
| 124 | mmu-mir-574-5p | 1 |
| 125 | emea/cpmp | 1 |
| 126 | hd-group | 1 |
| 127 | psba3r | 1 |
| 128 | 02-5b-318r | 1 |
| 129 | vas-totpar | 1 |
| 130 | csf/cubr | 1 |
| 131 | 5-fluorouracil-either | 1 |
| 132 | epi-marker | 1 |
| 133 | p.gly264ser | 1 |
| 134 | immunoregulator | 1 |
| 135 | bordas | 1 |
| 136 | nondiuretics | 1 |
| 137 | groove/strands | 1 |
| 138 | 7-o-rhamnosides | 1 |
| 139 | nonpregnancies | 1 |
| 140 | -ii-studies | 1 |
| 141 | qualifies | 16 |
| 142 | incongruities | 1 |
| 143 | amine-3-quinolinecarbonitriles | 2 |
| 144 | 3-methyl-2-vinylindoles | 2 |
| 145 | glymes | 1 |
| 146 | 3-azaxanthenes | 1 |
| 147 | pentachlorocyclohexenes | 1 |
| 148 | non-anthracyclines | 1 |
| 149 | 4-hydroxyprolines | 1 |
| 150 | 2-thioxo-1,3-oxazines | 1 |
| 151 | cost-pressures | 1 |
| 152 | 2,3-butadienoates | 1 |
| 153 | serves | 732 |
| 154 | acrgis | 1 |
| 155 | borealis | 1 |
| 156 | ach-iontophoresis | 1 |
| 157 | age-ldls | 1 |
| 158 | cyanogels | 1 |
| 159 | multivessels | 3 |
| 160 | transcriptional-levels | 1 |
| 161 | nano-wells | 1 |
| 162 | 2,3-diols | 1 |
| 163 | e.agglomerans | 1 |
| 164 | hemotoxins | 1 |
| 165 | germline-mutations | 1 |
| 166 | glucose-elevations | 1 |
| 167 | westerns | 1 |
| 168 | typaldos | 1 |
| 169 | mc-cfdps | 1 |
| 170 | ligament-tears | 1 |
| 171 | at2-blockers | 1 |
| 172 | δ-isomers | 1 |
| 173 | exhausters | 1 |
| 174 | iodophors | 1 |
| 175 | outcross | 3 |
| 176 | gerontologists | 1 |
| 177 | nonrapists | 1 |
| 178 | neglectus | 2 |
| 179 | t-511t | 1 |
| 180 | education-act | 1 |
| 181 | pasture-management | 1 |
| 182 | 'grandparent | 1 |
| 183 | time-to-dropout | 1 |
| 184 | tout | 1 |
| 185 | time-efficacy | 1 |
| 186 | 2004.grey | 1 |
| 187 | self-identify | 16 |
| 188 | tae/angiography | 1 |
| 189 | neurotransmitters-possibly | 1 |
| 190 | pejoratively | 1 |
| 191 | gly-x-gly | 1 |
| 192 | ficantly | 1 |
| 193 | diet-therapy | 1 |
| 194 | molecular-chemotherapy | 1 |
| 195 | multinodularity | 1 |
| 196 | ir-quartz | 1 |
| 197 | sba-15/ab₂ | 1 |